Presence of GAD Antibodies During Gestational Diabetes Mellitus Predicts Type 1 Diabetes
Open Access
- 1 August 2007
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 30 (8) , 1968-1971
- https://doi.org/10.2337/dc07-0157
Abstract
OBJECTIVE—We sought to study the frequency of β-cell–specific autoantibody markers in women with gestational diabetes mellitus (GDM) and to follow these women to estimate the risk of later development of type 1 diabetes.Keywords
This publication has 17 references indexed in Scilit:
- Large-for-gestational-age newborns in women with insulin-treated gestational diabetes under strict metabolic controlWiener klinische Wochenschrift, 2005
- The association between glucose challenge test, obesity and pregnancy outcome in 6390 non-diabetic womenThe Journal of Maternal-Fetal & Neonatal Medicine, 2005
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2005
- Predictive factors of developing diabetes mellitus in women with gestational diabetesActa Obstetricia et Gynecologica Scandinavica, 2002
- Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter studyDiabetes, 1997
- ICA512 autoantibody radioassayDiabetes, 1995
- Prevalence and Predictive Value of Islet Cell Antibodies and Insulin Autoantibodies in Women with Gestational DiabetesDiabetic Medicine, 1994
- A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDMDiabetologia, 1994
- Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in Type 1 (insulin-dependent) diabetes mellitusDiabetologia, 1987
- EVIDENCE FOR A LONG PREDIABETIC PERIOD IN TYPE I (INSULIN-DEPENDENT) DIABETES MELLITUSThe Lancet, 1981